Product Information

LYVISPAH 10 MG GRANULE PACKET is a brand product labeled by Amneal Pharmaceuticals LLC, priced at $3.4541 per EA under NDC 64896007709. Its NADAC has been published 37 times since Mar 19, 2025.

The High Outlier badge above means this manufacturer's average price in the baclofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LYVISPAH 10 MG GRANULE PACKET

baclofen
$3.4541per EA
High Outlier

Strength

10 mg/1

NDC

64896007709

Classification

Brand

Dosage Form

GRANULE

Route

ORAL

Last Updated

3/19/2025

Active Ingredients

BACLOFEN

Approval Type

New Drug (NDA)

FDA Application

NDA215422

On Market Since

6/1/2023

Pharmacological Classes

GABA A Agonists
GABA B Agonists
gamma-Aminobutyric Acid-ergic Agonist

Price Statistics

The NADAC for LYVISPAH 10 MG GRANULE PACKET has been published 37 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$3.4541 per EA
All-time high$3.4541 (Nov 26, 2025)
All-time low$3.4541 (Mar 19, 2025)
52-week high$3.4541
52-week low$3.4541
Median price$3.4541
Average price$3.4540
Largest weekly change0.0% (Mar 26, 2025)
Weeks tracked37
Tracking sinceMar 19, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LYVISPAH 10 MG GRANULE PACKET?

The current National Average Drug Acquisition Cost (NADAC) for LYVISPAH 10 MG GRANULE PACKET, manufactured by Amneal Pharmaceuticals LLC, is $3.4541 per EA (NDC 64896007709), effective Nov 26, 2025.

How has the price of LYVISPAH 10 MG GRANULE PACKET changed over time?

Over the history we have for it, the NADAC for LYVISPAH 10 MG GRANULE PACKET has held within roughly two percent of its current level. It has been tracked across 37 weekly CMS publications since Mar 19, 2025.

What are the highest and lowest recorded NADAC prices for LYVISPAH 10 MG GRANULE PACKET?

Since Mar 19, 2025, the NADAC for LYVISPAH 10 MG GRANULE PACKET has ranged from a low of $3.4541 (Mar 19, 2025) to a high of $3.4541 (Nov 26, 2025), with a median of $3.4541 per EA.

Are there cheaper alternatives to LYVISPAH 10 MG GRANULE PACKET?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BACLOFEN 10 MG TABLET, is $0.0332 per EA — about 99% below LYVISPAH 10 MG GRANULE PACKET.

Who manufactures LYVISPAH 10 MG GRANULE PACKET?

LYVISPAH 10 MG GRANULE PACKET (NDC 64896007709) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.